circ_C20orf11 enhances DDP resistance by inhibiting miR-527/YWHAZ through the promotion of extracellular vesicle-mediated macrophage M2 polarization in ovarian cancer

References

• Rauh-Hain JA, Krivak TC, Del Carmen MG, Olawaiye AB. Ovarian cancer screening and early detection in the general population. Rev Obstet Gynecol. 2011;4(1):15–21.
   PubMedGoogle Scholar
• Li Z, Niu H, Qin Q, Yang S, Wang Q, Yu C, Wei Z, Jin Z, Wang X, Yang A, others. lncRNA UCA1 mediates resistance to cisplatin by regulating the miR-143/FOSL2-signaling pathway in ovarian cancer. Mol Ther Nucleic Acids. 2019;17:92–101. doi:10.1016/j.omtn.2019.05.007.
   PubMedGoogle Scholar
• Liu Y, Feng Y, Liu H, Wu J, Tang Y, Wang Q. Real-time assessment of platinum sensitivity of primary culture from a patient with ovarian cancer with extensive metastasis and the platinum sensitivity enhancing effect by metformin. Oncol Lett. 2018;16(4):4253–4262.
   PubMed Web of Science ®Google Scholar
• Hasan S, Taha R, Omri HE. Current opinions on chemoresistance: an overview. Bioinformation. 2018;14(2):80–85. doi:10.6026/97320630014080.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Kaye SB. Ovarian cancer: strategies for overcoming resistance to chemotherapy. Nat Rev Cancer. 2003;3(7):502–516. doi:10.1038/nrc1123.
   PubMed Web of Science ®Google Scholar
• Yin M, Shen J, Yu S, Fei J, Zhu X, Zhao J, Zhai L, Sadhukhan A, Zhou J. Tumor-associated macrophages (TAMs): a critical activator in ovarian cancer metastasis. Onco Targets Ther. 2019;12:8687–8699. doi:10.2147/OTT.S216355.
   PubMed Web of Science ®Google Scholar
• Colvin EK. Tumor-associated macrophages contribute to tumor progression in ovarian cancer. Front Oncol. 2014;4:137. doi:10.3389/fonc.2014.00137.
   PubMedGoogle Scholar
• Larionova I, Cherdyntseva N, Liu T, Patysheva M, Rakina M, Kzhyshkowska J. Interaction of tumor-associated macrophages and cancer chemotherapy. Oncoimmunology. 2019;8(7):1596004. doi:10.1080/2162402X.2019.1596004.
   PubMed Web of Science ®Google Scholar
• Bardi GT, Smith MA, Hood JL. Melanoma exosomes promote mixed M1 and M2 macrophage polarization. Cytokine. 2018;105:63–72. doi:10.1016/j.cyto.2018.02.002.
   PubMed Web of Science ®Google Scholar
• Ham S, Lima LG, Chai EPZ, Muller A, Lobb RJ, Krumeich S, Wen SW, Wiegmans AP, Möller A. Breast cancer-derived exosomes alter macrophage polarization via gp130/STAT3 signaling. Front Immunol. 2018;9:871. doi:10.3389/fimmu.2018.00871.
   PubMed Web of Science ®Google Scholar
• Cheng L, Wang Y, Huang L. Exosomes from M1-polarized macrophages potentiate the cancer vaccine by creating a pro-inflammatory microenvironment in the lymph node. Molecular Therapy. 2017;25(7):1665–1675. doi:10.1016/j.ymthe.2017.02.007.
   PubMed Web of Science ®Google Scholar
• Wang L, Zhao F, Xiao Z, Yao L. Exosomal microRNA-205 is involved in proliferation, migration, invasion, and apoptosis of ovarian cancer cells via regulating VEGFA. Cancer Cell Int. 2019;19(1):281. doi:10.1186/s12935-019-0990-z.
   PubMed Web of Science ®Google Scholar
• Liang Z-X, Liu H-S, Wang F-W, Xiong L, Zhou C, Hu T, He X-W, Wu X-J, Xie D, Wu X-R, others, LncRNA RPPH1 promotes colorectal cancer metastasis by interacting with TUBB3 and by promoting exosomes-mediated macrophage M2 polarization. Cell Death Dis. 2019;10(11):829. doi: 10.1038/s41419-019-2077-0
   PubMed Web of Science ®Google Scholar
• Kanlikilicer P, Bayraktar R, Denizli M, Rashed MH, Ivan C, Aslan B, Mitra R, Karagoz K, Bayraktar E, Zhang X, others. Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer. EBioMedicine. 2018;38:100–112. doi:10.1016/j.ebiom.2018.11.004.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Ji M, Wang Q, He N, Circular LY. RNA Cdr1as upregulates SCAI to suppress cisplatin resistance in ovarian cancer via miR-1270 suppression. Mol Ther Nucleic Acids. 2019;18:24–33. doi:10.1016/j.omtn.2019.07.012.
   PubMedGoogle Scholar
• Gan X, Zhu H, Jiang X, Obiegbusi SC, Yong M, Long X, Hu J. CircMUC16 promotes autophagy of epithelial ovarian cancer via interaction with ATG13 and miR-199a. Mol Cancer. 2020;19(1):45. doi:10.1186/s12943-020-01163-z.
   PubMed Web of Science ®Google Scholar
• Shen M, Li T, Zhang G, Wu P, Chen F, Lou Q, Chen L, Yin X, Zhang T, Wang J. Dynamic expression and functional analysis of circRNA in granulosa cells during follicular development in chicken. BMC Genomics. 2019;20(1):96. doi:10.1186/s12864-019-5462-2.
   PubMedGoogle Scholar
• Quan G, Li J. Circular RNAs: biogenesis, expression and their potential roles in reproduction. J Ovarian Res. 2018;11(1):9. doi:10.1186/s13048-018-0381-4.
   PubMed Web of Science ®Google Scholar
• Chen Q, Zhang J, He Y, Wang Y. Hsa_circ_0061140 knockdown reverses FOXM1-mediated cell growth and metastasis in ovarian cancer through miR-370 sponge activity. Mol Ther Nucleic Acids. 2018;13:55–63. doi:10.1016/j.omtn.2018.08.010.
   PubMedGoogle Scholar
• Shen J, Zhu X, Fei J, Shi P, Yu S, Zhou J. Advances of exosome in the development of ovarian cancer and its diagnostic and therapeutic prospect. Onco Targets Ther. 2018;11:2831–2841. doi:10.2147/OTT.S159829.
   PubMed Web of Science ®Google Scholar
• Wang DY, Li N, Cui YL. Long noncoding RNA CCAT1 sponges miR-454 to promote chemoresistance of ovarian cancer cells to cisplatin by regulation of surviving. Cancer Res Treat. 2020;52(3):798-814. doi: 10.4143/crt.2019.498.
   Web of Science ®Google Scholar
• Liu H, Han L, Liu Z, Gao N. Long noncoding RNA MNX1-AS1 contributes to lung cancer progression through the miR-527/BRF2 pathway. J Cell Physiol. 2019;234(8):13843–13850. doi:10.1002/jcp.28064.
   PubMed Web of Science ®Google Scholar
• Klymenko Y, Nephew KP. Nephew KP Epigenetic crosstalk between the tumor microenvironment and ovarian cancer cells: a therapeutic road less traveled. Cancers. 2018;10(9):295. doi:10.3390/cancers10090295.
   PubMed Web of Science ®Google Scholar
• Huo W, Zhu XM, Pan XY, Du M, Sun Z, Li ZM. MicroRNA-527 inhibits TGF-β/SMAD induced epithelial-mesenchymal transition via downregulating SULF2 expression in non-small-cell lung cancer. Math Biosci Eng. 2019;16(5):4607–4621. doi:10.3934/mbe.2019231.
   PubMed Web of Science ®Google Scholar
• Liu J, Hou K, Ji H, Mi S, Yu G, Hu S, Wang J. Overexpression of circular RNA circ-CDC45 facilitates glioma cell progression by sponging miR-516b and miR-527 and predicts an adverse prognosis. J Cell Biochem. 2020;121(1):690–697. doi:10.1002/jcb.29315.
   PubMed Web of Science ®Google Scholar
• Hong L, Chen W, Xing A, Wu D, Wang S. Inhibition of tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta (YWHAZ) overcomes drug resistance and tumorigenicity in ovarian cancer. Cell Physiol Biochem. 2018;49(1):53–64. doi:10.1159/000492839.
   PubMedGoogle Scholar
• Mashouri L, Yousefi H, Aref AR, Ahadi AM, Molaei F, Alahari SK. Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance. Mol Cancer. 2019;18(1):75. doi:10.1186/s12943-019-0991-5.
   PubMed Web of Science ®Google Scholar
• Azmi AS, Bao B, Sarkar FH. Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review. Cancer Metastasis Rev. 2013;32(3–4):623–642. doi:10.1007/s10555-013-9441-9.
   PubMed Web of Science ®Google Scholar
• Zhang C, Ji Q, Yang Y, Li Q, Wang Z. Exosome: function and role in cancer metastasis and drug resistance. Technol Cancer Res Treat. 2018;17:1533033818763450. doi:10.1177/1533033818763450.
   Web of Science ®Google Scholar
• Wu M, Wang G, Hu W, Yao Y, Yu X-F. Emerging roles and therapeutic value of exosomes in cancer metastasis. Mol Cancer. 2019;18(1):53. doi:10.1186/s12943-019-0964-8.
   PubMed Web of Science ®Google Scholar